Medtronic, the renowned medical device company, has petitioned the Eighth Circuit for a reversal of a decision that previously rejected its pricing method for licensing intellectual property to its Puerto Rican subsidiary.
The long-standing case revolves around the accusation that Medtronic manipulated the intercompany arrangement to underreport its income. However, the company staunchly denies these allegations.
This saga adds to the growing list of global corporations grappling with complex legal and tax implications of intercompany transfer pricing.
For further information, please visit this page.